We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.51B
AUM Growth
-$82.4M
Cap. Flow
-$100M
Cap. Flow %
-4%
Top 10 Hldgs %
22.43%
Holding
1,530
New
76
Increased
658
Reduced
739
Closed
53

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.83M
2
DD icon
DuPont de Nemours
DD
+$6.5M
3
ABBV icon
AbbVie
ABBV
+$5.98M
4
CELG
Celgene Corp
CELG
+$3.68M
5
NFLX icon
Netflix
NFLX
+$3.26M

Sector Composition

Rank Sector Weight
1 Technology 26.5%
2 Healthcare 18.58%
3 Financials 10.77%
4 Communication Services 10.27%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$651B
$15.5M 0.62%
208,035
-28,109
-12% -$2.25M
PYPL icon
27
PayPal
PYPL
$49.5B
$15.3M 0.61%
201,077
-10,901
-5% -$865K
CMCSA icon
28
Comcast
CMCSA
$79.7B
$14.4M 0.57%
420,521
+19,640
+5% +$762K
ILMN icon
29
Illumina
ILMN
$29.4B
$14M 0.56%
60,901
-4,296
-7% -$985K
WFC icon
30
Wells Fargo
WFC
$261B
$13M 0.52%
248,564
-29,399
-11% -$1.75M
CVX icon
31
Chevron
CVX
$388B
$11.4M 0.46%
100,287
-10,385
-9% -$1.24M
REGN icon
32
Regeneron Pharmaceuticals
REGN
$68.8B
$11.3M 0.45%
32,831
-2,195
-6% -$763K
TSM icon
33
TSMC
TSM
$2.09T
$10.5M 0.42%
240,344
-32,138
-12% -$1.4M
PFE icon
34
Pfizer
PFE
$140B
$10.5M 0.42%
311,573
-14,530
-4% -$500K
BIDU icon
35
Baidu
BIDU
$35.8B
$10.5M 0.42%
46,874
+1,003
+2% +$247K
ADI icon
36
Analog Devices
ADI
$181B
$10.4M 0.42%
114,457
+3,546
+3% +$323K
LRCX icon
37
Lam Research
LRCX
$382B
$10.3M 0.41%
505,730
+19,550
+4% +$387K
DD icon
38
DuPont de Nemours
DD
$18.6B
$10.1M 0.4%
62,385
-35,910
-37% -$6.5M
ALXN
39
DELISTED
Alexion Pharmaceuticals
ALXN
$9.94M 0.4%
89,171
-7,626
-8% -$912K
BA icon
40
Boeing
BA
$165B
$9.86M 0.39%
30,065
+1,695
+6% +$573K
UNH icon
41
UnitedHealth
UNH
$382B
$9.83M 0.39%
45,939
+2,177
+5% +$497K
CRM icon
42
Salesforce
CRM
$134B
$9.83M 0.39%
84,515
-9,044
-10% -$1.04M
C icon
43
Citigroup
C
$222B
$9.82M 0.39%
145,538
-20,216
-12% -$1.52M
ADBE icon
44
Adobe
ADBE
$89.5B
$9.8M 0.39%
45,365
+3,849
+9% +$783K
HD icon
45
Home Depot
HD
$332B
$9.7M 0.39%
54,424
+4,055
+8% +$761K
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.07T
$9.44M 0.38%
47,304
-12,100
-20% -$2.48M
BKNG icon
47
Booking.com
BKNG
$138B
$9.43M 0.38%
113,350
+4,650
+4% +$366K
EBAY icon
48
eBay
EBAY
$48.6B
$8.95M 0.36%
222,511
-18,690
-8% -$774K
MRK icon
49
Merck
MRK
$324B
$7.59M 0.3%
146,078
-6,898
-5% -$373K
V icon
50
Visa
V
$677B
$7.55M 0.3%
63,147
-5,746
-8% -$696K

Similar funds

Profund Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Profund Advisors held 1,530 positions worth $2.51B, down 3.2% from $2.59B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Profund Advisors withdrew a net $100M in Q1 2018, closing 53 positions and reducing 739 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $2.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Profund Advisors opened a new position in Okta worth $1.55M.

  • Profund Advisors's largest Q1 2018 buy was Okta: 38,807 shares worth $1.55M.
  • Profund Advisors added most to Agilent Technologies in Q1 2018, an estimated $7.07M increase.
  • Profund Advisors's biggest Q1 2018 reduction was Amgen, cutting an estimated $7.83M.
  • Profund Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $2.76M.
  • Profund Advisors's ten largest holdings make up 22% of its $2.51B portfolio in Q1 2018.
  • Profund Advisors opened 76 new positions and closed 53 in Q1 2018.
  • Profund Advisors's portfolio value fell 3.2% quarter-over-quarter to $2.51B.

Based on Profund Advisors's 13F filing for Q1 2018, filed 14 May 2018.